Search

everythinglearnresearchcommunity

for

Search:↓

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

Low Vitamin D is common in people with Alopecia Areata, but its impact on the condition needs more research.

Platelet-Rich Plasma treatment improved hair growth and reduced inflammation in patients with patchy hair loss, but not in total hair loss, and Optical Coherence Tomography was useful in tracking this progress.

Congenital alopecia areata may have genetic links and topical corticosteroids are an effective treatment.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Lower vitamin D levels are linked to higher CRP levels in people with a type of hair loss called alopecia areata.

Alopecia areata treatment varies, with no optimal method established yet.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

A man lost all his hair after stopping hepatitis C treatment and it didn't grow back.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

High-dose corticosteroids and methotrexate had a modest effect on severe childhood alopecia, but side effects and relapse were concerns.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

People with certain allergic conditions or higher white blood cell counts have more severe hair loss, and treating hair and nail side effects early in melanoma therapy can improve quality of life.

Intramuscular triamcinolone and pulse therapy with oral predonine are effective for alopecia areata with manageable side effects, but better relapse prevention is needed.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Denosumab treatment for osteoporosis can cause hair loss.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Gut microbiota changes might play a role in alopecia areata, and microbiome-targeted treatments show promise.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Alopecia areata often starts before age 20, is more common in women, and may have a genetic link with other autoimmune diseases.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.